Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple essential microbial biomolecules – non-specific is a collective term used to describe the broad array of molecular targets affected by general antiseptic and disinfectant agents. Rather than binding to a single high-affinity receptor or enzyme, these agents exert their antimicrobial effects by causing widespread damage to various cellular components, including cytoplasmic membranes, metabolic enzymes, and genetic material (StatPearls, 2023). This multi-target approach is characteristic of biocides like iodine, silver, and alcohols, which induce rapid protein coagulation and oxidative stress across a wide spectrum of bacteria, fungi, and viruses (PubMed, PMID: 15489352). Because the mechanism is physical or broadly chemical rather than site-specific, it is difficult for microbes to develop resistance, but this also results in a lower therapeutic index compared to targeted antibiotics. In clinical databases, this entry serves as a placeholder for drugs that lack a single, defined molecular target and instead interact with numerous essential microbial structures simultaneously (TTD Database, 2024).
Drugs targeting these biomolecules typically act through non-specific chemical reactions such as protein denaturation, oxidation of sulfhydryl groups, membrane disruption, or cross-linking of nucleic acids and proteins, leading to rapid microbial cell death.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple essential microbial biomolecules – non-specific.